ChromoGenics postpones Annual General Meeting and delivery and publication of the Annual Report for 2022
The Board of Directors of ChromoGenics has decided to postpone the Annual General Meeting and the delivery and publication of the Annual Report for 2022.
For practical reasons, the Board of Directors of ChromoGenics has decided to postpone the Annual General Meeting until the 27th of June 2023 as well as the publication of the Annual Report for 2022 until the 6th of June 2023. Previously communicated date for the Annual General Meeting was the 25th of May 2023 and the 27th of April 2023 for the Annual Report for 2022.
Contact:
Fredrik Fränding, CEO
Erik Elfström, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430
E-mail: info@chromogenics.com
ChromoGenics
This information was submitted, through the care of the above contact person, for publication on 21 April 2023 at 13:15 CEST.
This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.
About ChromoGenics
ChromoGenics is a proptech company producing smart dynamic glass that improves indoor environments and well-being and lowers buildings’ energy consumption, operating expenses and impact on the climate. The company’s product ConverLight® Dynamic is based on a unique patented technology from the Ångström Laboratory in Uppsala, where electrochromic coatings are sputtered onto plastic film. The result is a dynamic film that can be laminated between glass layers, which provides buildings with good solar protection and lowered environmental impact from production, transport and use. The dynamic film is easy to transport and can be applied by local partners in the glass industry, which means it is possible to avoid long-distance shipping of bulky glass. All of ChromoGenics’ products strive to follow the key words environment and health. This means a focus on environmentally friendly material, lower energy consumption, increased access to daylight and views and improved indoor comfort.
The company’s production facilities in Uppsala have been financed in part by a conditional loan from the Swedish Energy Agency. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market, and Vator Securities is the Certified Adviser.